Skip to main content

Table 5 Univariate models assessing association between selected variables and PFDI-201, UDI-62, PFIQ-73 scores

From: A cross-sectional study on pelvic floor symptoms in women living with Female Genital Mutilation/Cutting

Variables

PFDI-201

UDI-62

PFIQ-72

Mean ± SD (Me: p25-p75)

p-value

Mean ± SD (Me: p25-p75)

p-value

Mean ± SD (Me: p25-p75)

p-value

Type of FGM/C

 

0.282

 

0.323

 

0.136

 III

53.7 ± 57.0 (26.1: 12.5–84.6)

 

21.0 ± 25.3 (10.4: 0.0–33.4)

 

46.6 ± 56.5 (21.5: 0.0–90.5)

 

 I, II

43.4 ± 43.4 (28.2: 10.5–68.7)

 

17.0 ± 20.4 (12.5: 0.0–20.8)

 

32.0 ± 48.2 (9.5: 0.0–47.6)

 

Type of FGM/C

 

0.067

 

0.115

 

0.213

 Infibulated

63.4 ± 68.2 (26.1: 13.5–84.6)

 

25.0 ± 27.4 (12.5: 3.1–50.0)

 

50.5 ± 62.2 (9.5: 0.0–90.5)

 

 Non-infibulated

44.3 ± 43.7 (26.6: 20.5–75)

 

17.5 ± 21.6 (10.4: 0.0–25.0)

 

37.0 ± 49.9 (19.0: 0.0–57.1)

 

Age at FGM/C

 

0.516

 

0.247

 

0.019

  < 1 year old

38.5 ± 40.0 (25.0: 7.3–68.7)

 

14.5 ± 19.7 (4.2: 0.0–20.8)

 

22.7 ± 34.4 (4.8: 0.0–28.6)

 

 1–5 years old

61.7 ± 65.0 (30.8: 13.6–103.7)

 

22.2 ± 27.0 (12.5: 2.1–31.3)

 

33.3 ± 42.2 (21.5: 7.1–31.0)

 

 6–10 years old

50.5 ± 52.1 (36.5: 13.0–76.1)

 

19.7 ± 23.7 (8.3: 0.0–31.3)

 

46.7 ± 56.9 (19.0: 0.0–81.0)

 

  > 10 years old

81.6 ± 72.7 (65.6: 10.4–170.8)

 

32.2 ± 30.7 (16.6: 4.2–66.6)

 

80.6 ± 73.7 (90.5: 9.5–128.6)

 

 Unknown/no answer

40.5 ± 41.7 (18.8: 14.6–66.7)

 

19.1 ± 21.2 (12.5: 4.2–20.8)

 

44.1 ± 59.7 (19.1: 0.0–57.2)

 

Past violent events

 

0.001

 

0.002

 

0.001

 Yes

66.9 ± 57.3 (52.1: 17.7–107.3)

 

26.6 ± 25.7 (16.6: 4.2–52.1)

 

58.4 ± 59.3 (48.4: 2.4–100.0)

 

 None/no answer

35.2 ± 42.6 (17.2: 6.8–54.7)

 

13.8 ± 19.8 (4.2: 0.0–16.7)

 

26.2 ± 43.7 (4.8: 0.0–31.0)

 

Time in Switzerland

 

0.346

 

0.835

 

0.010

  < 6 months

79.3 ± 71.1 (73.2: 18.8–87.5)

 

25.8 ± 27.3 (16.7: 4.2–41.7)

 

89.5 ± 65.8 (95.3: 23.8–133.3)

 

 6–12 months

46.1 ± 51.4 (28.7: 13.5–67.8)

 

16.2 ± 19.6 (8.3: 4.2–20.8)

 

36.0 ± 51.1 (7.2: 0.0–80.9)

 

 12–60 months

44.1 ± 45.8 (22.9: 14.6–68.7)

 

19.2 ± 23.8 (12.5: 0.0–29.2)

 

42.9 ± 61.7 (9.5: 0.0–57.1)

 

  > 5 years

50.2 ± 53.3 (25.0: 8.3–79.1)

 

19.9 ± 24.0 (8.3: 0.0–33.3)

 

29.9 ± 35.5 (19.0: 0.0–52.4)

 

Age in categories

 

0.001

 

0.004

 

0.999

  < 25

36.3 ± 31.5 (26.1: 4.2–66.7)

 

13.9 ± 19.9 (4.2: 0.0–16.6)

 

37.5 ± 52.6 (0.0: 0.0–81.0)

 

 25–35

40.4 ± 42.9 (18.8: 12.5–67.8)

 

15.9 ± 20.4 (8.3: 0.0–20.8)

 

43.0 ± 57.3 (14.3: 0.0–81.0)

 

  ≥ 35

76.5 ± 68.6 (67.7: 12.5–129.2)

 

30.5 ± 27.9 (22.9: 4.2–58.3)

 

38.5 ± 47.8 (23.8: 0.0–57.2)

 

Dichotomized BMI

 

0.006

 

0.011

 

0.390

  < 25.0

39.4 ± 40.3 (23.0: 9.4–66.2)

 

15.3 ± 20.1 (8.3: 0.0–18.8)

 

37.4 ± 49.3 (11.9: 0.0–57.2)

 

  ≥ 25.0

65.5 ± 63.8 (39.1: 13.5–108.2)

 

26.2 ± 26.8 (16.7: 2.1–50.0)

 

45.9 ± 60.0 (19.1: 0.0–81.0)

 

Ongoing pregnancy

 

0.153

 

0.044

 

0.085

 No

54.4 ± 55.7 (35.5: 13.5–77.1)

 

22.6 ± 25.5 (12.5: 0.0–34.4)

 

46.8 ± 57.3 (23.8: 0.0–81)

 

 Yes

40.3 ± 43.3 (17.7: 8.3–70.8)

 

13.8 ± 17.9 (8.3: 0.0–20.8)

 

29.3 ± 44.3 (9.5: 0.0–47.6)

 

Parity

 

0.575

 

0.628

 

0.010

 Nulliparous

53.3 ± 58.4 (32.4: 14.6–69.3)

 

20.5 ± 25.0 (10.4: 0.0–25.0)

 

57.6 ± 56.1 (42.9: 0.0–90.5)

 

 Primiparous

47.5 ± 42.5 (26.1: 12.5–75.0)

 

20.4 ± 20.4 (12.5: 4.2–29.2)

 

33.5 ± 55.7 (4.7: 0.0–47.6)

 

 Multiparous

47.2 ± 51.9 (18.8: 8.3–84.6)

 

18.1 ± 24.2 (4.2: 0.0–33.3)

 

29.0 ± 46.1 (9.5: 0.0–44.4)

 

Previous episiotomy

 

0.464

 

0.231

 

0.521

 No

47.8 ± 53.0 (26.0: 10.4–70.8)

 

18.2 ± 22.7 (8.3: 0.0–25.0)

 

43.1 ± 55.0 (19.0: 0.0–81.0)

 

 Yes

51.1 ± 49.3 (26.1: 12.5–94.8)

 

21.2 ± 24.0 (12.5: 0.0–33.3)

 

35.8 ± 51.6 (9.5: 0.0–57.2)

 

 Unknown

88.0 ± 81.7 (88.0: 30.2–145.8)

 

43.8 ± 44.2 (43.8: 12.5–75.0)

 

39.6 ± 56.0 (39.6: 0.0–79.2)

  1. p-values from linear regression models (univariate analyses)
  2. Other tested variables not shown in the table: previous reinfibulation, origin, smoking, coffee consumption
  3. 1Pelvic Floor Distress Inventory
  4. 2Urinary Distress Inventory
  5. 3Pelvic Floor Impact Questionnaire